School of Medicine
Showing 1-4 of 4 Results
Chul Hong Kim
Visiting Associate Professor, Radiology - Rad/Molecular Imaging Program at Stanford
Bio Dr. Chulhong Kim studied for his Ph.D. degree and postdoctoral training at Washington University in St. Louis, St. Louis, Missouri under the supervision of Dr. Lihong V. Wang, Dr. Younan Xia, and Dr. Samuel Achilefu. He currently holds Mueunjae Chaired Professorship and is an Associate Professor of Creative IT Engineering, Mechanical Engineering, Electrical Engineering, and Interdisciplinary Bioscience and Bioengineering at Pohang University of Science and Technology (POSTECH) in Republic of Korea. He is also a Visiting Associate Professor of Radiology at Stanford University. Before he joined the department, he was an Assistant Professor of Biomedical Engineering at the University at Buffalo, the State University of New York from Aug 2010 to Jan 2013. He was the recipients of the 2017 IEEE Engineering in Medicine and Biology Society (EMBS) Academic Early Career Achievement Award, the 2017 Korean Academy of Science and Technology Young Scientist Award (The Korean Presidential and Highest Award for Engineers under 40), the 2016 Nightingale Award from The International Federation for Medical and Biological Engineering, and the 2017 Korean Society of Medical & Biological Engineering Young Investigator Award ?Contributions to multi-scale photoacoustic imaging from super-resolution atomic force photoactivated microscopy for research to systems for clinical applications.? He has published 121 peer-reviewed journal articles (Nature Nanotechnology, Nature Materials, Chemical Reviews, Light Science & Applications, Radiology, etc) and 67 conference proceedings articles. His team also filed and/or registered 34 domestic/international patents. His Google Scholar h-index and citations have reached 45 and over 7,800, respectively. His group?s works have been selected for the 2016, 2017, and 2019 Seno Medical Best Paper Award Finalists in Photons Plus Ultrasound Conference (the largest conference in the field), Photonics West, SPIE. He also co-authored six book chapters. He has currently served as an Editorial Board Member of Scientific Reports, Photoacoustics Journal, etc. He has served as an Organizing Committee for the conference on ?Photons plus Ultrasound: Imaging and Sensing? and ?High-Speed Biomedical Imaging and Spectroscopy: Toward Big Data Instrumentation and Management? held annually under auspices of SPIE (Photonics West) and as a Theme Co-Chair for the 39th and 40th Annual International Conference of the IEEE EMBS. He has served as a journal reviewer >100, including for Nature Photonics, Nature Communication, Light Science & Applications, and etc.. He has delivered a numerous invited presentations (>130) in technical conferences and seminars in universities. He is also elected as a member of Young Korean Academy of Science and Technology (Y-KAST). Particularly, his lab developed photoacoustic gastro-intestinal tract imaging using organic agents, photoacoustic cystography, clinical photoacoustic/ultrasound imaging scanner (clinically translated with Alpinion Medical), fast optical-resolution photoacoustic microscopy based on a 2-axis water-proof MEMS scanner (licensed to MGB; spin-off company, PAMsTECH and OPTICHO), virtual intraoperative photoacoustic surgical microscopy, raster scanning based photoacoustic whole body imaging of small animals, combined photoacoustic and optical coherence tomography using a single pulsed broadband laser source, acoustic-radiation force induced ultrasound-modulated optical tomography, etc.
Professor of Medicine (Oncology) and of Radiology (Molecular Imaging Program at Stanford) at the Stanford University Medical Center
Current Research and Scholarly Interests Dr. Kummar?s research interests focus on developing novel therapies for cancer. She specializes in conducting pharmacokinetic and pharmacodynamic driven first-in-human trials tailored to make early, informed decisions regarding the suitability of novel molecular agents for further clinical investigation. Her studies integrate genomics and laboratory correlates into early phase trials. She is interested in alternate trial designs to facilitate rational drug selection based on human data and help expedite drug development timelines. She has published numerous articles in medical journals and serves on a number of national and international scientific committees.